LENZ Therapeutics News

LENZ Therapeutics | 8-K: Current report

Oct 28, 2024 20:13

LENZ Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Sep 12, 2024 04:12

LENZ Therapeutics | 8-K: Current report

Aug 12, 2024 20:10

LENZ Therapeutics | 8-K: Current report

Jul 15, 2024 20:24

LENZ Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 21, 2024 20:35

LENZ Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 10, 2024 02:30

LENZ Therapeutics | 8-K: Current report

Apr 3, 2024 19:37

LENZ Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Mar 30, 2024 04:48

Therapeutics | 8-K: Current report

Mar 23, 2024 02:11

Graphite Bio | 8-K: Current report

Mar 20, 2024 04:37

Graphite Bio | 8-K: Current report

Mar 15, 2024 04:41

Graphite Bio | 8-K: Current report

Mar 9, 2024 06:17

Graphite Bio | 8-K: Current report

Mar 5, 2024 19:12

Graphite Bio | 8-K: Current report

Dec 26, 2023 13:00

Graphite Bio | 8-K: Current report

Nov 15, 2023 21:06

Graphite Bio | 8-K: Current report

Oct 31, 2023 04:08

Graphite Bio | 8-K/A: Current report (Amendment)

Sep 14, 2023 04:06

Graphite Bio | 8-K: Current report

Aug 24, 2023 04:06

Graphite Bio | 8-K: Current report

Aug 3, 2023 04:07

Graphite Bio | 8-K: Current report

Jul 20, 2023 20:02